Gene Expression Analysis Market Trends, Industry & Size 2031

Report Description

Gene Expression Analysis Market Outlook 2031

The global gene expression analysis market size was USD 4.50 Billion in 2022 and is estimated to reach USD 9.61 Billion by 2031 register a high CAGR 8.8% during the forecast period, between 2023 - 2031. The growth of the market is attributed to the lowering of the cost of gene sequencing and rising demand for gene study for clinical research to enhance the treatment for several illness.

The approach of obtaining data from a gene to analyze the behaviour of biological systems is known as gene expression analysis (GEA). It includes some major processes such as gene translation, transcription, protein post-translational modification, and ribonucleic acid (RNA) splicing. The information gleaned from this examination is used to create RNA, proteins, and a variety of microbiological products.

Get Free Sample Report

They are also used in the development of new medications and improvement of existing diagnostic systems. GEA is now widely regarded as critical healthcare method in explaining the mechanisms that can produce a wide range of medical treatment for various diseases, and as a result, it has multiple applications in bio marking, pharmacogenomics, diagnostics, and toxicology.

Gene Expression Analysis Market Trends, Drivers, Restraints, and Opportunities

• Declining cost of sequencing and increasing genetic research to better understand the underlying causes of many disorders are key factors propelling the market.
• Growing usage of targeted molecular therapies as well as the increasing need for personalized medicines are important drivers of the market.
• Rising prevalence of chronic diseases such as TB, cancer, and cardiovascular and genetic problems is expected to boost the market significantly in the coming years.
• Hybridization-based detection and the usage of predesigned oligonucleotides along with the scarcity of trained professionals are major challenges anticipated to hamper the market growth.
• New drug discovery, technological development, as well as expanding research activities are projected to provide profitable growth opportunities for the market in the long run.

Scope of The Gene Expression Analysis Market Report

The report on the global gene expression analysis market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Global Gene Expression Analysis Market Segment Insights

Kits & reagent segment is projected to hold significant market share

Based on product types, the global gene expression analysis market is divided into DNA chip/microarray, kits & reagent, and others. The kits & reagent segment is projected to hold significant market share owing to the presence of a large number of firms offering various types of kits and reagents for gene expression. In addition, the development of improved goods developed for specialized applications further propels the segment.

Get Free Sample Report

cDNA synthesis & conversion segment to account for substantial share

 On the basis of processes, the market is segmented into cDNA synthesis & conversion, data analysis & interpretation, PCR analysis, purification, and sample collection. The cDNA synthesis & conversion segment is anticipated to account for substantial share of the market due to the availability of a wide selection of cDNA synthesis kits to meet the study needs in terms of optimal reaction temperature, sample size, and a number of reactions.

Furthermore, a surge in cDNA synthesis and library preparation kit product introductions is a key factor driving the segment.

High-plex gene expression analysis segment to register a substantial growth rate

In terms of capacities, the global gene expression analysis market is bifurcated into low-to-mid-plex gene expression analysis and high-plex gene expression analysis. The high-plex gene expression analysis segment is anticipated to register a substantial growth rate during the projection timeline. The segment growth is owing to the increase in the adoption of gene expression scrutiny, intended for various genomic research reviews.

Furthermore, when compared to qPCR and other traditional technologies, high-plex analysis lowers hands-on time. The procedure is also highly accurate and easy since it eliminates the need for first probe validation. The introduction of spatially resolved coupled with multiplexed digital characterisation systems is likely to boost the segment further.

RNA exp. segment to expand at a robust pace

Based on techniques, the market is segregated into promoter analysis, protein exp. & posttranslational modification analysis, and RNA exp. The promoter analysis segment is further classified as chromatin immunoprecipitation assays, gel shift assays, and in vitro transcription/nuclear run-on assays. The protein exp. & posttranslational modification analysis segment is further divided into 2-d gel electrophoresis, immunoassays, mass spectrometry, and western blotting.

Furthermore, the RNA exp. segment is sub-categorized as DNA microarrays, northern blotting, PCR techniques, and RNA-Seq. The RNA exp. segment is anticipated to expand at a robust pace in the coming years. High-throughput technologies, such as RNA sequencing (RNA-seq) and cDNA microarray that have been adopted frequently to replace prior procedures.

As a result, technological developments in RNA extraction procedures and tools along with the availability of a variety of products to fulfil various research demands are further pushing to enhance the usage of these techniques for gene expression investigation.

Drug discovery & development segment to hold substantial market share

On the basis of applications, the global gene expression analysis market is fragmented into biotechnology & microbiology, clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment has its sub unit, RNA Exp. The drug discovery & development segment is estimated to hold substantial market share.

A growth in the study of gene expression outlines of SARS-CoV-2 receptors for in silico drug innovation for COVID-19 is a significant driving force of the segment. An August 2020 study analysed gene expression patterns to investigate the key activities of Angiotensin-converting enzyme 2 (ACE2)-related genes.

Get Free Sample Report

Pharmaceutical & biotech companies segment to account for a key share

In terms of end-users, the market is segmented into academic institutes & research centres, pharmaceutical & biotech companies, and others. The pharmaceutical & biotech companies segment is projected to account for a key market share. Gene expression analysis products and services are used by pharmaceutical and biotechnology companies to meet clinical research goals such as medication development and discovery as well as biotech research.

Biopharmaceutical businesses are primarily concerned with the development of targeted treatments, particularly for the treatment of complex diseases, cancer, and uncommon genetic abnormalities. Contract research organizations (CROs) provide a variety of gene expression analysis services including NGS gene expression profiling. This is increasing the need for CROs' gene expression analysis services.

North America is expected to dominate the market

In terms of regions, the global gene expression analysis market is categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market due to the wide research and development of gene therapy as well as favorable government initiatives encouraging robust clinical experiment for gene expression.

Moreover, the emphasis on gene expression studies and the availability of funding for innovative technology for research from governments are propelling the gene expression analysis market in the region.

Get Free Sample Report